Latest healthtech and biotech deals
The largest from last week:
🇺🇸 Apogee Therapeutics, a biotech company addressing immunological and inflammatory disorders, raised $149M in Series B.
🇺🇸 Celcuity, a clinical-stage biotechnology company that seeks to extend the lives of cancer patients by pursuing an integrated therapeutic and companion diagnostic strategy, raised $100M in Private Placement VC. The round follows dosage of the first patient in Celcuity's Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib, Celcuity's lead therapeutic candidate.
Other notable deals from around the globe:
🇮🇳 Wellbeing Nutrition, an online store specialist in female health and nutrition, raised $10M in Series B.
🇫🇷 Semeia, digital health company that provides software that helps in medical follow-up and consultation, raised €8M. Semeia focuses in the remote monitoring of chronic diseases, including chronic kidney disease and transplantation, and recently acquired OPTIM'CARE.
Read up on all the latest health deals in Dealroom.co